title: Bortezomib-thalidomide-dexamethasone versus bortezomib-cyclophosphamide-dexamethasone as induction therapy prior to autologous stem cell transplantation in multiple myeloma.
authors.affiliation: Haematology Department, UMR 892, University Hospital, Nantes, France. philippe.moreau@chu-nantes.fr.
authors.forename: Philippe
authors.initials: P
authors.lastname: Moreau
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Mary
authors.forename: Michel
authors.initials: M
authors.lastname: Attal
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*
keywords: autologous stem cell transplantation; bortezomib; induction therapy; multiple myeloma